Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin

Cancer Research

Volumn 67, Issue 3, 2007, Pages 890-900

  Sharma, Mukesh K ^a   Mansur, David B ^a   Reifenberger, Guido ^b   Perry, Arie ^a   Leonard, Jeffrey R ^a   Aldape, Kenneth D ^c   Albin, Meredith G ^a   Emnett, Ryan J ^a   Loeser, Simon ^b   Watson, Mark A ^a   Nagarajan, Rakesh ^a   Gutmann, David H ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROFIBROMIN;

ANIMAL MODEL; ARTICLE; ASTROCYTOMA; BRAIN REGION; BRAIN TUMOR; CONTROLLED STUDY; EPENDYMOMA; GENE EXPRESSION; GENE IDENTIFICATION; GLIOMA; MICROARRAY ANALYSIS; MOUSE; NEURAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; RNA ISOLATION;

ADOLESCENT; ADULT; ALGORITHMS; ASTROCYTOMA; CHILD; CHILD, PRESCHOOL; CLUSTER ANALYSIS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; INFRATENTORIAL NEOPLASMS; MALE; MIDDLE AGED; NEUROFIBROMATOSIS 1; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SUPRATENTORIAL NEOPLASMS;

EID: 33847068802     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-06-0973     Document Type: Article

References (48)

1. Kleihues P, Sobin LH. World Health Organization classification of tumors. Cancer 2000;88:2887.
2. Listernick R, Darling C, Greenwald M, Strauss L, Charrow J. Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history. J Pediatr 1995;127:718-22.
3. Kluwe L, Hagel C, Tatagiba M, et al. Loss of NF1 alleles distinguish sporadic from NF1-associated pilocytic astrocytomas. J Neuropathol Exp Neurol 2001;60:917-20.
4. Wimmer K, Eckart M, Meyer-Puttlitz B, Fonatsch C, Pietsch T. Mutational and expression analysis of the NF1 gene argues against a role as tumor suppressor in sporadic pilocytic astrocytomas. J Neuropathol Exp Neurol 2002;61:896-902.
5. von Deimling A, Louis DN, Menon AG, et al. Deletions on the long arm of chromosome 17 in pilocytic astrocytoma. Acta Neuropathol (Berl) 1993;86:81-5.
6. Phelan CM, Liu L, Ruttledge MH, et al. Chromosome 17 abnormalities and lack of TP53 mutations in paediatric central nervous system tumours. Hum Genet 1995;96:684-90.
7. Willert JR, Daneshvar L, Sheffield VC, Cogen PH. Deletion of chromosome arm 17p DNA sequences in pediatric high-grade and juvenile pilocytic astrocytomas. Genes Chromosomes Cancer 1995;12:165-72.
8. White FV Anthony DC, Yunis EJ, et al. Nonrandom chromosomal gains in pilocytic astrocytomas of childhood. Hum Pathol 1995;26:979-86.
9. Zattara-Cannoni H, Gambarelli D, Lena G, et al. Are juvenile pilocytic astrocytomas benign tumors? A cytogenetic study in 24 cases. Cancer Genet Cytogenet 1998;104:157-60.
10. Sanoudou D, Tingby O, Ferguson-Smith MA, Collins W, Coleman N. Analysis of pilocytic astrocytoma by comparative genomic hybridization. Br J Cancer 2000;82:1218-22.
11. Duerr EM, Rollbrocker B, Hayashi Y, et al. PTEN mutations in gliomas and glioneuronal tumors. Oncogene 1998;16:2259-64.
12. Sharma MK, Zehnbauer BA, Watson MA, Gutmann DH. RAS pathway activation and an oncogenic RAS mutation in sporadic pilocytic astrocytoma. Neurology 2005;65:1335-6.
13. Ohira M, Oba S, Nakamura Y, et al. Expression profiling using a tumor-specific cDNA microarray predicts the prognosis of intermediate risk neuroblastomas. Cancer Cell 2005;7:337-50.
14. Sotiriou C, Wirapati P, Loi S, et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst 2006;98:262-72.
15. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc, Ser B 1995;57:289-300.
16. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001;98:5116-21.
17. Dasgupta B, Yi Y, Chen DY, Weber JD, Gutmann DH. Proteomic analysis reveals hyperactivation of the mammalian target of rapamycin pathway in neurofibromatosis 1-associated human and mouse brain tumors. Cancer Res 2005;65:2755-60.
18. Dasgupta B, Gutmann DH. Neurofibromin regulates neural stem cell proliferation, survival, and astroglial differentiation in vitro and in vivo. J Neurosci 2005;25:5584-94.
19. -ΔΔCT method. Methods 2001;25:402-8.
20. Shibata T, Yamada K, Watanabe M, et al. Glutamate transporter GLAST is expressed in the radial glia-astrocyte lineage of developing mouse spinal cord. J Neurosci 1997;17:9212-9.
21. Gutmann DH, Hedrick NM, Li J, et al. Comparative gene expression profile analysis of neurofibromatosis 1-associated and sporadic pilocytic astrocytomas. Cancer Res 2002;62:2085-91.
22. Rickman DS, Bobek MP, Misek DE, et al. Distinctive molecular profiles of high-grade and low-grade gliomas based on oligonucleotide microarray analysis. Cancer Res 2001;61:6885-91.
23. Wong KK, Chang YM, Tsang YT, et al. Expression analysis of juvenile pilocytic astrocytomas by oligonucleotide microarray reveals two potential subgroups. Cancer Res 2005;65:76-84.
24. Taylor MD, Poppleton H, Fuller C, et al. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 2005;8:323-35.
25. Chateil JF, Soussotte C, Pedespan JM, et al. MRI and clinical differences between optic pathway tumours in children with and without neurofibromatosis. Br J Radiol 2001;74:24-31.
26. Barreau C, Paillard L, Mereau A, Osborne HB. Mammalian CELF/Bruno-like RNA-binding proteins: molecular characteristics and biological functions. Biochimie 2005;88:515-25.
27. Timchenko NA, Cai ZJ, Welm AL, et al. RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J Biol Chem 2001;276:7820-6.
28. Sundholm-Peters NL, Yang HK, Goings GE, Walker AS, Szele FG. Radial glia-like ceils at the base of the lateral ventricles in adult mice. J Neurocytol 2004;33:153-64.
29. Hartfuss E, Galli R, Heins N, Gotz M. Characterization of CNS precursor subtypes and radial glia. Dev Biol 2001;229:15-30.
30. Ando H, Kobayashi M, Tsubokawa T, et al. Lhx2 mediates the activity of Six3 in zebrafish forebrain growth. Dev Biol 2005;287:456-68.
31. Bulchand S, Grove EA, Porter FD, Tole S. LIM-homeodomain gene Lhx2 regulates the formation of the cortical hem. Mech Dev 2001;100:165-75.
32. Porter FD, Drago J, Xu Y, et al. Lhx2, a LIM homeobox gene, is required for eye, forebrain, and definitive erythrocyte development Development 1997;124:2935-44.
33. Monaghan AP, Grau E, Bock D, Schutz G. The mouse homolog of the orphan nuclear receptor tailless is expressed in the developing forebrain. Development 1995;121:839-53.
34. Land PW, Monaghan AP. Abnormal development of zinc-containing cortical circuits in the absence of the transcription factor Tailless. Brain Res Dev Brain Res 2005;158:97-101.
35. Oliver G, Mailhos A, Wehr R, et al. Six3, a murine homologue of the sine oculis gene, demarcates the most anterior border of the developing neural plate and is expressed during eye development Development 1995;121:4045-55.
36. Lagutin OV, Zhu CC, Kobayashi D, et al. Six3 repression of Wnt signaling in the anterior neuroectoderm is essential for vertebrate forebrain development. Genes Dev 2003;17:368-79.
37. Goulding MD, Chalepakis G, Deutsch U, Erselius JR, Grass P. Pax-3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J 1991;10:1135-47.
38. Terzic J, Saraga-Babic M. Expression pattern of PAX3 and PAX6 genes during human embryogenesis. Int J Dev Biol 1999;43:501-8.
39. Matsumoto K, Nishihara S, Kamimura M, et al. The prepattern transcription factor Irx2, a target of the FGF8/MAP kinase cascade, is involved in cerebellum formation. Nat Neurosci 2004;7:605-12.
40. Matsunaga E, Araki I, Nakamura H. Role of Pax3/7 in the tectum regionalization. Development 2001;128:4069-77.
41. Lakkis MM, Golden JA, O'Shea KS, Epstein JA. Neurofibromin deficiency in mice causes exencephaly and is a modifier for Splotch neural tube defects. Dev Biol 1999;212:80-92.
42. Pinto SS, Gottfried C, Mendez A, et al. Immunocontent and secretion of S100B in astrocyte cultures from different brain regions in relation to morphology. FEBS Lett 2000;486:203-7.
43. Zschocke J, Bayatti N, Clement AM, et al. Differential promotion of glutamate transporter expression and function by glucocorticoids in astrocytes from various brain regions. J Biol Chem 2005;280:34924-32.
44. Won CL, Oh YS. cAMP-induced stellation in primary astrocyte cultures with regional heterogeneity. Brain Res 2000;887:250-8.
45. Peters JL, Earnest BJ, Tjalkens RB, Cassone VM, Zoran MJ. Modulation of intercellular calcium signaling by melatonin in avian and mammalian astrocytes is brain region-specific. J Comp Neurol 2005;493:370-80.
46. Wink MR, Braganhol E, Tamajusuku AS, et al. Extracellular adenine nucleotides metabolism in astrocyte cultures from different brain regions. Neurochem Int 2003;43:621-8.
47. 3H]glutamate by primary astrocyte cultures. I. Effects of different sera and time in culture. Glia 1992;6:1-8.
48. Horiguchi S, Takahashi J, Kishi Y, et al Neural precursor cells derived from human embryonic brain retain regional specificity. J Neurosci Res 2004;75:817-24.